ayx1
Nucleic acidexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2013 (NCT01731730)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ayx1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04104919 | Phase 2 | Dec 31, 2019 | Adynxx, Inc., National Institute on Drug Abuse (NIDA) |
| NCT03797612 | Phase 2 | May 1, 2019 | Adynxx, Inc. |
| NCT02807428 | Phase 2 | Feb 20, 2017 | Adynxx, Inc. |
| NCT02081703 | Phase 2 | May 1, 2014 | Adynxx, Inc. |
| NCT01731730 | Phase 2 | Jan 1, 2013 | Adynxx, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Adynxx, Inc. | For profit | 5 | 5 | 1 | 2013 |
| National Institute on Drug Abuse (NIDA) | Government | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1